Galichia Medical Group names CE

The News Review:

- Galichia Medical Group names CE
- Hearing Improved: First Successful Medical Treatment For Tumor …
- Police: Woman found in fish pond had medical condition
- Westlake Village medical marijuana center’s owner to make his case …
- Truth Sleuth: What are medical isotopes?

Galichia Medical Group names CE
Bizjournals.com
Meyer who is currently medical director and employee benefits manager for IMA of Kansas will move start with Galichia Medical Group on Aug. Meyer said job presents a unique opportunity. “Galichia is poised to grow which offers me a very exciting opportunity to grow with it” Meyer said in a written statement. “Being a physician working in the insurance industry I’ve learned a great deal about the business of health care and I know a lot about medicine.

Hearing Improved: First Successful Medical Treatment For Tumor …
Science Daily (press release)
Plotkin notes "Based on the results of this study we have just opened the first formal clinical trial of a drug treatment for NF2. We are testing an exciting new oral VEGF inhibitor that will be easier for patients to take – bevacizumab is administered intravenously – and may have fewer side effects. "Plotkin is an assistant professor of Neurology at Harvard Medical School (HMS). Formerly an assistant professor of Radiation ncology at HMS di Tomaso recently joined the Novartis Institutes for BioMedical Research. Additional co-authors of the NEJM report are Anat Stemmer-Rachamimov MD MGH Pathology; Fred Barker MD MGH Neurosurgery; Timothy Padera PhD Alex Tyrrell PhD and Rakesh Jain PhD MGH Radiation ncology; Gregory Sorensen MD MGH Radiology and Chris Halpin PhD Massachusetts Eye and Ear Infirmary. The study was supported by the HMS Center for Neurofibromatosis and Allied Disorders Neurofibromatosis Inc. New England Children’s Tumor Foundation the Department of Defense the National Institutes of Health and the MGH Executive Committee on Research.

Police: Woman found in fish pond had medical condition
Salt Lake Tribune
Dorothy Gifford 73 likely lost consciousness and fell into the shallow fish pond Sunday evening said West Valley City police Capt. The report did not say what her pre-existing condition was McLachlan said. Medical examiners have not named an official cause of death pending the final autopsy report but her death is not suspicious McLachlan said.
Related from Telefenua: Canadian telephone scam costs FL senior citizen $2500

Westlake Village medical marijuana center’s owner to make his case …
Los Angeles Times
The Westlake Village planning director sent the owner of Amazing Healing Supply located on La Baya Drive a cease-and-desist letter June 17 informing him that the dispensary was prohibited from operating in a business park zone according to city documents. An attorney for owner Ron Glantz filed an appeal with the city and will make his case tonight during the City Council meeting. "They're claiming it's not zoned properly and we claim it is" said attorney Michael Margolin who is representing Glantz. "We believe the language [of the ordinance] is vague and over-broad.

Truth Sleuth: What are medical isotopes?
London Free Press
The reactor at Chalk River nt. makes the isotope molybdenum-99. This is refined into technetium-99m another medical isotope which is then injected into patients. Its radioactivity can be viewed by imaging equipment to help doctors detect cancer and heart defects. Why is there a global shortage? Five commercial reactors supply 95% of world demand. The Chalk River reactor supplies more than one-third. The Petten HFR reactor in The Netherlands also provides just over one-third while the remaining three reactors in South Africa Belgium and France make up the difference.

Written by admin on July 8th, 2009 with no comments.
Read more articles on News.

Related articles

No comments

There are still no comments on this article.

Leave your comment...

If you want to leave your comment on this article, simply fill out the next form:




You can use these XHTML tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong> .